Bone Densitometer Global Market Report 2024

A bone densitometer is a medical device designed to measure bone mineral density, providing crucial information about the health of bones. Typically utilized in hospitals and diagnostic centers, a bone densitometer employs advanced X-ray technology to assess the minerals and density of bones.

Key types of bone densitometers include DXA systems (dual-energy X-ray absorptiometry), peripheral bone densitometers, radiographic absorptiometry scanners, and quantitative ultrasound scanners. DXA systems, in particular, represent an advanced form of X-ray technology used to measure bone mineral density. This technology employs a minimal dose of ionizing radiation to generate images of the inside of the body, aiding in the assessment of bone loss. Bone densitometers find application in various healthcare settings, including hospitals, clinics, diagnostic and imaging centers. They are instrumental in diagnosing conditions such as osteoporosis, osteopenia, rheumatoid arthritis, and for measuring body composition.

The bone densitometer market research report is one of a series of new reports that provides bone densitometer market statistics, including bone densitometer industry global market size, regional shares, competitors with a bone densitometer market share, detailed bone densitometer market segments, market trends and opportunities, and any further data you may need to thrive in the bone densitometer industry. This bone densitometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bone densitometer market size has grown strongly in recent years. It will grow from $1.27 billion in 2023 to $1.38 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth observed during the historical period can be attributed to several factors, including the aging population, increased awareness about the importance of bone health, the rise in healthcare infrastructure, and overall economic growth.

The bone densitometer market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forecast period can be attributed to factors such as the rise in preventive healthcare measures, increased investment in research and development, growing healthcare spending, and the increasing prevalence of osteoporosis. Key trends expected during this period include the integration of artificial intelligence (AI) in bone health diagnostics, a focus on sustainability and green technology in medical equipment, the emergence of wearable bone health monitoring devices, the implementation of patient engagement solutions, and the adoption of remote monitoring technologies in the healthcare sector.

The increasing incidence of osteoporosis is anticipated to drive the demand for bone densitometers. Osteoporosis, characterized by a decrease in bone density and strength leading to fragile bones, is attributed to factors such as low calcium intake, genetic disorders, and gastrointestinal surgery. Bone densitometers play a crucial role in calculating quantitative bone density through specific technologies and applications, aiding in the diagnosis and treatment of osteoporosis. With an estimated 1.5 million Americans experiencing osteoporosis-related fractures each year, costing $19 billion, as reported by Amgen in 2022, there is a heightened demand for bone densitometers. The global increase in osteoporosis cases is expected to propel the growth of the bone densitometer market.

The growth of the aging population is poised to contribute to the expansion of the bone densitometer market. The aging population, characterized by a rising percentage of elderly individuals, significantly impacts the economy, healthcare systems, and social support networks. Older individuals are more prone to developing osteoporosis, emphasizing the need for early detection and prevention. Bone densitometry plays a vital role in the diagnosis and treatment of osteoporosis in older individuals, potentially reducing healthcare costs while improving patient outcomes. The Australian Institute of Health and Welfare reported in June 2023 that the proportion of Australians aged 65 and above increased from 4.6 percent in 1922 to 16.2 percent in 2021. This demographic shift is a driving force behind the growth of the bone densitometer market.

Technological advancements represent a prominent trend in the bone densitometer market, with major companies focusing on delivering advanced solutions to meet customer demands and enhance market positions. Companies are incorporating next-generation technologies, such as radiography, computed tomography, fluoroscopy, mammography, diffraction, 3D visualization, and modeling, into their bone densitometer products. For instance, Italian medical equipment manufacturer Echolight SPA offers an innovative radiation-free bone densitometry solution using Radiofrequency Echographic Multi Spectrometry (REMS) technology. REMS technology provides a radiation-free approach to assess the bone situation of the lumbar vertebral column and femoral neck, overcoming limitations of traditional techniques like DXA and QUS. This emphasis on technological innovation is driving the evolution of the bone densitometer market.

Major players in the bone densitometer market are strategically investing to enhance their capabilities, as exemplified by Zürcher Kantonalbank's investment in MEDIMAPS GROUP. Zürcher Kantonalbank made a significant investment of $20 million in Medimaps Group, a Swiss imaging software provider specializing in bone health evaluation using regular medical images. This investment was facilitated through Swisscanto Invest, Zürcher Kantonalbank's asset management arm. The financing round, led by Swisscanto Invest, also included participation from Swiss Entrepreneurs Fund, Swisscom Ventures, and Verve Ventures. In December 2021, Medimaps Group announced the successful raising of $20 million in institutional funding. This capital infusion aimed to support the development and commercialization of an artificial intelligence portfolio for bone health evaluation using routine medical images. The funds were earmarked for expanding the product line through the creation and launch of proprietary AI applications for bone health evaluation across the United States, Europe, Asia, and Latin America.

In April 2022, Newman Regional Health, a U.S.-based community hospital, forged a collaboration with Hologic to incorporate the Horizon DXA bone densitometry system into its healthcare offerings. This strategic partnership allowed Newman Regional Health to enhance its male and female health and well-being services. The Horizon DXA system, developed by Hologic, a U.S.-based manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products, is equipped with advanced imaging technology that provides excellent image quality and cutting-edge diagnostic tools. This system supports the early detection and treatment of osteoporosis, thereby contributing to improved healthcare outcomes for patients.

Major companies operating in the bone densitometer market include Diagnostic Medical Systems SA, GE Healthcare Technologies Inc., Hologic Inc., BeamMed Ltd., Demetech AB, Osteometer Meditech Inc., OSTEOSYS Corp., Trivitron Healthcare Private Limited, Swissray International Inc., MEDILINK Global Ltd., Xingaoyi Medical Equipment Co. Ltd., Echolight S.p.a, Eurotec Medical Systems srl, Scanflex Healthcare AB, Medonica Co. Ltd., CyberLogic Inc., Oscare Medical Oy, L'Acn Srl., Shenzhen Xray Electric Co. Ltd., YOZMA BMTech Co. Ltd., Nanoomtech Co. Ltd., FURUNO Electric Co. Ltd., ARTANN Laboratories Inc., StemLab Inc., CooperSurgical Inc., Medtronic PLC, Siemens AG, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd.

North America was the largest region in the bone densitometer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone densitometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bone densitometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The bone densitometer market consists of sales of central DEXA and peripheral DEXA. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.